NEUROPACE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.52 USD | +0.24% |
|
-36.75% | -17.36% |
| 05-13 | Morgan Stanley Lowers Price Target on NeuroPace to $9.50 From $13, Keeps Equalweight Rating | MT |
| 05-08 | NeuroPace, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
- Stock Market
- Equities
- NPCE Stock
- News NeuroPace, Inc.
- MarketScreener Strategies
